Butterfly Network

Butterfly Network is a United States medical technology company focused on point-of-care ultrasound (POCUS). Its offering is designed to bring ultrasound into clinical assessment, diagnosis, and treatment, including settings where clinicians need portable imaging at the patient’s point of care. The company’s website describes a solution built around whole-body ultrasound probes and a connected set of software, artificial-intelligence capabilities, workflow management, and education resources. The company presents its products as a platform rather than as an imaging device alone. Its website describes support for individual practitioners, health systems, and medical education, and says that more than 145,000 customers around the world use Butterfly products. The intended users therefore include clinicians and healthcare organizations seeking to incorporate ultrasound into routine care and training. The supplied material does not specify the full list of countries served, sales channels, or the precise division of customers by market. Butterfly’s public-facing product identity is led by the Butterfly iQ3, described on the homepage as its point-of-care ultrasound offering. The company also promotes Butterfly Embedded, a program or product line for ultrasound-enabled technologies. More broadly, its platform combines probes with an app or software experience, AI, workflow management, and education. The supplied evidence does not identify individual AI functions, probe specifications, regulatory clearances, or the detailed terms of its software services. Founded in 2011, Butterfly Network was established by medical technology entrepreneur Jonathan Rothberg. It is a publicly traded company under the ticker BFLY. Its commercial positioning emphasizes making ultrasound more accessible and integrating it into everyday clinical workflows. The homepage highlights applications for clinicians, hospitals, individual practices, health systems, and medical education. It also advertises subscription-free purchasing offers at certain times; this is a time-limited promotion rather than evidence that all products or services are permanently subscription-free. Butterfly Network remains an active medical technology brand. Its public website emphasizes the iQ3 and a broader POCUS management approach. The evidence supplied here does not establish the company’s current headquarters, present ownership structure, named current executives, or a complete history of its product launches and corporate transactions, so those details are not asserted.

Butterfly Network was founded in 2011 by Jonathan Rothberg, a medical technology entrepreneur. The company’s central commercial aim has been to make ultrasound available beyond conventional imaging departments by developing portable point-of-care ultrasound technology. Its approach is associated with a compact probe platform and a connected software experience, positioning ultrasound as a tool that clinicians can use as part of assessment and care at the point of service. Over time, Butterfly has presented its offering as more than a hardware product. The company’s current homepage describes whole-body probes integrated with AI, workflow management software, and an education suite. It markets services to individual practitioners, health systems, and medical education, reflecting an effort to support both device use and broader clinical adoption. The website says more than 145,000 customers around the world use Butterfly, although the supplied evidence does not provide a date or methodology for that figure. The Butterfly iQ3 is the prominent product named in the supplied official homepage evidence. The company also promotes Butterfly Embedded as a new wave of ultrasound-enabled technologies. These offerings sit within the broader point-of-care ultrasound category, where the company’s stated value proposition is to bring ultrasound into everyday assessments, diagnoses, and treatments. The supplied material does not provide launch dates for these offerings, nor enough detail to establish their technical specifications or availability in each market. Butterfly Network is publicly traded under ticker BFLY and remains active. Its recent public-facing messaging emphasizes POCUS management and a connected solution spanning probes, software, AI, workflow, and education. The homepage also describes a subscription-free promotional offer for clinicians, with an end date of September 30 in the cited page text; because the year is not specified in the evidence, that offer is not treated here as a current or continuing policy. The available evidence does not establish the company’s present headquarters, current ownership details, executive roster, or a complete record of corporate milestones.

• 2011

  Butterfly Network founded

• Butterfly Network becomes publicly traded

• Butterfly iQ3 featured on the official homepage

An integrated point-of-care ultrasound solution combining whole-body probes with AI, workflow management software, and education resources for clinicians, health systems, and medical education.

• Butterfly iQ3

  A point-of-care ultrasound offering highlighted by the official homepage.

• Butterfly Embedded

  Promoted by the company as ultrasound-enabled technologies.

• Butterfly POCUS platform

  A solution described as combining whole-body probes, AI, workflow management software, and education resources.

• 2022

  Class action complaint filed against Butterfly Network

  The Klein Law Firm announced that a class action complaint had been filed on behalf of Butterfly Network shareholders, alleging that the company violated federal securities laws and made materially false or misleading statements or failed to disclose information. These are allegations in the complaint; the source reports no determination.

  Source

Read more

• 2022.03.01

  Reported2022.03.01

  Class action complaint filed against Butterfly Network[2]Class action complaint filed against Butterfly Networkprnewswire.com

  The Klein Law Firm announced that a class action complaint had been filed on behalf of Butterfly Network shareholders, alleging that the company violated federal securities laws and made materially false or misleading statements or failed to disclose information. These are allegations in the complaint; the source reports no determination.

Read more

1. 1The clear answer in point-of-care ultrasound | Butterfly iQ3butterflynetwork.com
2. 2Class action complaint filed against Butterfly Networkprnewswire.com